Occupational transdermal poisoning with synthetic cannabinoid cumyl-PINACA

被引:19
作者
Dobaja, Mojca [1 ]
Grenc, Damjan [1 ]
Kozelj, Gordana [2 ]
Brvar, Miran [1 ,3 ]
机构
[1] Univ Med Ctr Ljubljana, Div Internal Med, Ctr Clin Toxicol & Pharmacol, Zaloska Cesta 7, Ljubljana 1000, Slovenia
[2] Univ Ljubljana, Inst Forens Med, Fac Med, Ljubljana, Slovenia
[3] Univ Ljubljana, Inst Pathophysiol, Fac Med, Ljubljana, Slovenia
关键词
Synthetic cannabinoids; transdermal exposure; occupational poisoning; potency; safety; cumyl-PINACA; SGT-24; PERMEATION; SPICE;
D O I
10.1080/15563650.2016.1278224
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Context: Synthetic cannabinoids are getting more popular among young people and illicit manufacturers. We report a case series of occupational transdermal poisoning with synthetic cannabinoids. Case details: Three customs inspectors got in contact with a sticky substance with their fingertips because they were not wearing protection gloves and the delivered package was damaged. Despite washing their hands with water, signs of synthetic cannabinoids intoxication started occurring half an hour after exposure. On arrival at the Emergency Department six hours later, they were somnolent, lethargic and confused. They showed signs of mydriasis, blurred vision, ataxia, weakness, numbness, tachycardia and one of them had orthostatic hypotension. Two days later, they were feeling much better and reported amnesia and slowed perception of time after exposure. Toxicology analysis by LC-MS/MS revealed synthetic cannabinoid cumyl-PINACA (SGT-24) in their blood samples taken on admission. cumyl-PINACA was also confirmed with NMR method in liquid samples seized at the airport. It was 98% pure substance with the purpose of being diluted and sold further in the drug market by drug dealer. Discussion: This case series highlights the possible transdermal exposure to synthetic cannabinoids oil resulting in prolonged cannabinoid syndrome.
引用
收藏
页码:193 / 195
页数:3
相关论文
共 12 条
[1]  
Angerer V, 2015, 7 EUR AC FOR SCI C S
[2]   Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA [J].
Banister, Samuel D. ;
Moir, Michael ;
Stuart, Jordyn ;
Kevin, Richard C. ;
Wood, Katie E. ;
Longworth, Mitchell ;
Wilkinson, Shane M. ;
Beinat, Corinne ;
Buchanan, Alexandra S. ;
Glass, Michelle ;
Connor, Mark ;
McGregor, Iain S. ;
Kassiou, Michael .
ACS CHEMICAL NEUROSCIENCE, 2015, 6 (09) :1546-1559
[3]   Crystal Structure of the Human Cannabinoid Receptor CB1 [J].
Hua, Tian ;
Vemuri, Kiran ;
Pu, Mengchen ;
Qu, Lu ;
Han, Gye Won ;
Wu, Yiran ;
Zhao, Suwen ;
Shui, Wenqing ;
Li, Shanshan ;
Korde, Anisha ;
Laprairie, Robert B. ;
Stahl, Edward L. ;
Ho, Jo-Hao ;
Zvonok, Nikolai ;
Zhou, Han ;
Kufareva, Irina ;
Wu, Beili ;
Zhao, Qiang ;
Hanson, Michael A. ;
Bohn, Laura M. ;
Makriyannis, Alexandros ;
Stevens, Raymond C. ;
Liu, Zhi-Jie .
CELL, 2016, 167 (03) :750-+
[4]   Top 10 Facts You Need to Know About Synthetic Cannabinoids: Not So Nice Spice [J].
Kemp, Ann M. ;
Clark, Molly S. ;
Dobbs, Thomas ;
Galli, Robert ;
Sherman, Justin ;
Cox, Robert .
AMERICAN JOURNAL OF MEDICINE, 2016, 129 (03) :240-+
[5]  
Manini AF, 2015, CLIN TOXICOL, V53, P356
[6]  
Mckeever RG, 2014, CLIN TOXICOL, V52, P362
[7]   Cannabidiol bioavailability after nasal and transdermal application: effect of permeation enhancers [J].
Paudel, Kalpana S. ;
Hammell, Dana C. ;
Agu, Remigius U. ;
Valiveti, Satyanarayana ;
Stinchcomb, Audra L. .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2010, 36 (09) :1088-1097
[8]   Spicing things up: synthetic cannabinoids [J].
Spaderna, Max ;
Addy, Peter H. ;
D'Souza, Deepak Cyril .
PSYCHOPHARMACOLOGY, 2013, 228 (04) :525-540
[9]  
Streich HT, 2014, CLIN TOXICOL, V52, P365
[10]   A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment [J].
Tait, Robert J. ;
Caldicott, David ;
Mountain, David ;
Hill, Simon L. ;
Lenton, Simon .
CLINICAL TOXICOLOGY, 2016, 54 (01) :1-13